The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, in collaboration with the Korea ...

Russell Broadbent and a group comprising scientists, health professionals, lawyers, and academics, wrote to the Prime ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

including LUNAR® lipid nanoparticle formulation processes and STARR® sa-mRNA drug substance manufacturing.” ...

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation ...

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...